Status:
TERMINATED
Factors Associated With End Stage Liver Disease
Lead Sponsor:
NYU Langone Health
Conditions:
Cirrhosis
Hepatic Encephalopathy
Eligibility:
All Genders
18-70 years
Brief Summary
100 ambulatory cirrhotic patients attending a liver transplant clinic will undergo a comprehensive clinical evaluation for severity of liver disease, anemia, depression, and fatigue. Fatigue will be a...
Detailed Description
100 ambulatory patients with cirrhosis will be prospectively evaluated for severity of liver disease, anemia, and fatigue; exclusion criteria includes chronic renal insufficiency and recent alcohol us...
Eligibility Criteria
Inclusion
- male or female, age b/w 18-70 years, inclusive
- willingly and able to provide written consent
- Diagnosed with Cirrhosis
- Able to read and write in English
Exclusion
- Inability to provide consent
- Not within age range of 18-70 years, inclusive
- Not diagnosed with Cirrhosis
- Unable to read or write in English
- Unable to walk
Key Trial Info
Start Date :
July 1 2012
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 1 2014
Estimated Enrollment :
27 Patients enrolled
Trial Details
Trial ID
NCT01846819
Start Date
July 1 2012
End Date
December 1 2014
Last Update
January 25 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
NYU School of Medicine, Schwartz Health Care Center Suite 4C
New York, New York, United States, 10016